BlackRock, Inc. 13D and 13G filings for Mirati Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-31 2:08 pm Purchase |
2023-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
BlackRock Inc. BLK |
3,866,202 5.500% |
1,109,527 (+40.25%) |
Filing |
| 2022-01-10 12:54 pm Sale |
2021-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
BlackRock Inc. BLK |
2,756,675 4.990% |
-1,523,737 (-35.60%) |
Filing |
| 2021-01-29 5:23 pm Purchase |
2020-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
BlackRock Inc. BLK |
4,280,412 8.500% |
1,523,713 (+55.27%) |
Filing |